Aminobenzenesulfonic auristatin E structure
|
Common Name | Aminobenzenesulfonic auristatin E | ||
|---|---|---|---|---|
| CAS Number | 1800462-99-0 | Molecular Weight | 753.00 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C37H64N6O8S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Aminobenzenesulfonic auristatin EAminobenzenesulfonic auristatin E is a drug-linker conjugate for ADC with potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic[1]. |
| Name | Aminobenzenesulfonic auristatin E |
|---|
| Description | Aminobenzenesulfonic auristatin E is a drug-linker conjugate for ADC with potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic[1]. |
|---|---|
| Related Catalog | |
| Target |
Auristatin |
| In Vitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. |
| References |
[1]. Kevin HAMBLETT, et al. Anti-her2 biparatopic antibody-drug conjugates and methods of use. |
| Molecular Formula | C37H64N6O8S |
|---|---|
| Molecular Weight | 753.00 |
| InChIKey | AZVFJNPRFUTRNO-RAEOHFLNSA-N |
| SMILES | CCC(C)C(C(CC(=O)N1CCCC1C(OC)C(C)C(=O)NS(=O)(=O)c1ccc(N)cc1)OC)N(C)C(=O)C(NC(=O)C(C(C)C)N(C)C)C(C)C |